PULSION Medical Systems SE engages in the development, production, and distribution of monitoring, diagnosis, and therapy control systems for recording physiological parameters of hospitalized, seriously ill, and intensive care patients. Its technologies include the PiCCO platform, a system used in intensive care medicine for the treatment of critically ill patients; PulsioFlex, which offers technology in the field of perioperative medicine; PiCCO catheter used to monitor the cardiovascular system; and ProAQT, a sensor used in medicine for high-risk patients and high-risk interventions. The company was founded in 1990 and is headquartered in Feldkirchen, Germany.
Metrics to compare | PUS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipPUSPeersSector | |
---|---|---|---|---|
P/E Ratio | 10.7x | −2.2x | −0.5x | |
PEG Ratio | 0.05 | −0.04 | 0.00 | |
Price/Book | - | 1.7x | 2.6x | |
Price / LTM Sales | 4.1x | 2.3x | 3.3x | |
Upside (Analyst Target) | - | 7.8% | 43.5% | |
Fair Value Upside | Unlock | −2.9% | 6.9% | Unlock |